TP53 and neoplasm: Regarding to TP53 mutations, the GSTM2 was decreasingly expressed in tumor tissues from patients with wild type TP53 and mutated TP53 versus normal tissues, but the TP53 mutations did not affect the GSTM2 expression (Figure 2H).